206558-34-1 Usage
Uses
Used in Organic Synthesis:
(1-Benzyl-piperidin-4-ylidene)-acetic acid Methyl ester is used as a reagent in organic synthesis for the creation of various chemical compounds.
Used in Pharmaceutical Production:
(1-Benzyl-piperidin-4-ylidene)-acetic acid Methyl ester is used as an intermediate in the production of various types of pharmaceuticals, contributing to the development of new medications.
Used in Agrochemical Production:
(1-Benzyl-piperidin-4-ylidene)-acetic acid Methyl ester is also used as an intermediate in the production of agrochemicals, aiding in the development of new agricultural products.
Used in Research and Development:
(1-Benzyl-piperidin-4-ylidene)-acetic acid Methyl ester is utilized in research and development for the creation of new compounds with potential medical or industrial applications, driving innovation in these fields.
Safety Precautions:
As with all chemicals, (1-Benzyl-piperidin-4-ylidene)-acetic acid Methyl ester should be handled and stored with care, following proper safety precautions and guidelines to ensure the safety of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 206558-34-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,6,5,5 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 206558-34:
(8*2)+(7*0)+(6*6)+(5*5)+(4*5)+(3*8)+(2*3)+(1*4)=131
131 % 10 = 1
So 206558-34-1 is a valid CAS Registry Number.
206558-34-1Relevant academic research and scientific papers
TETRAHYDROIMDIDAZOPYRAZINE DERIVATIVES AS CGRP RECEPTOR ANTAGONISTS
-
Page/Page column 20, (2014/05/07)
The disclosure generally relates to the novel compounds of formula I, including pharmaceutically acceptable salts, which are CGRP receptor antagonists. The disclosure also relates to pharmaceutical compositions and methods for using the compounds in the t
Novel therapeutic agents for the treatment of migraine
-
Page/Page column 47, (2010/02/14)
The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their u
